839 Selective targeting of GARP-LTGFß Axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell anti-tumor immunity
Published in Regular and Young Investigator Award Abstracts, 2022
Background
Immune checkpoint blockade (ICB) targeting programed cell death protein 1 (PD-1) and its ligand has revolutionized cancer immunotherapy. Unfortunately, while some cancer patients experience robust and lasting remission following treatment, most fail to respond clinically. Accumulation of transfor…
Recommended citation: Anqi Li, Yuzhou Chang, No‐Joon Song, Xingjun Wu, Dongjun Chung, Brian Riesenberg, Maria Velegraki, Hyunwoo Kwon, et al.. (2022). "839 Selective targeting of GARP-LTGFß Axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell anti-tumor immunity" Regular and Young Investigator Award Abstracts.
Download Paper